Human endothelial dihydrofolate reductase low activity limits vascular tetrahydrobiopterin recycling

Free Radical Biology and Medicine

Volumn 63, Issue , 2013, Pages 143-150

  Whitsett, Jennifer ^a   Filho, Artur Rangel ^b   Sethumadhavan, Savitha ^a   Celinska, Joanna ^a   Widlansky, Michael ^a   Vasquez Vivar, Jeannette ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Dihydrobiopterin; Dihydrofolate; Endothelial drug metabolism; Free radicals; Methotrexate; Nitric oxide synthase

Indexed keywords

DIHYDROBIOPTERIN; DIHYDROFOLATE REDUCTASE; FOLIC ACID; NITRIC OXIDE; TETRAHYDROBIOPTERIN;

ARTICLE; CONTROLLED STUDY; COULOMETRY; COW; DIASTEREOISOMER; ENDOTHELIUM CELL; ENZYME ACTIVITY; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; LENTIVIRINAE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

BOVINAE; MURINAE;

EID: 84884840975     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.04.035     Document Type: Article

References (41)

1. List, BM; Klösch, B; Völker, C; Gorren, AC; Sessa, WC; Werner, ER; Kukovetz, WR; Schmidt, K; Mayer, B. Characterization of bovine endothelial nitric oxide synthase as a homodimer with down-regulated uncoupled NADPH oxidase activity: tetrahydrobiopterin binding kinetics and role of haem in dimeriza-tion. Biochem. J. 323:159-165; 1997. (Pubitemid 27153889)
2. Bec, N; Gorren, AC; Voelker, C; Mayer, B; Lange, R. Reaction of neuronal nitric-oxide synthase with oxygen at low temperature: evidence for reductive activation of the oxy-ferrous complex by tetrahydrobiopterin. J. Biol. Chem 273:13502-13508; 1998. (Pubitemid 28268391)
3. Vásquez-Vivar, J; Kalyanaraman, B; Martásek, P; Hogg, N; Masters, BS; Karoui, H; Tordo, P; Pritchard Jr. KA Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc. Natl. Acad. Sci. USA 95:9220-9225; 1998. (Pubitemid 28506212)
4. Vásquez-Vivar, J; Martásek, P; Whitsett, J; Joseph, J; Kalyanaraman, B. The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study. Biochem. J. 362:733-739; 2002. (Pubitemid 34242326)
5. Thöny, B; Auerbach, G; Blau, N. Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem. J. 347:1-16; 2000. (Pubitemid 30199034)
6. Nichol, CA; Lee, CL; Edelstein, MP; Chao, JY; Duch, DS. Biosynthesis of tetrahydrobiopterin by de novo and salvage pathways in adrenal medulla extracts, mammalian cell cultures, and rat brain in vivo. Proc. Natl. Acad. Sci. USA 80:1546-1550; 1983. (Pubitemid 13052446)
7. Berger, SH; Pittman, DL; Wyatt, MD. Uracil in DNA: consequences for carcinogenesis and chemotherapy. Biochem. Pharmacol. 76:697-706; 2008.
8. Bailey, SW; Ayling, JE. The extremely slow and variable activity of dihydrofo-late reductase in human liver and its implications for high folic acid intake. Proc. Natl. Acad. Sci. USA 106:15424-15429; 2009.
9. Hsieh, YC; Skacel, NE; Bansal, N; Scotto, KW; Banerjee, D; Bertino, JR; Abali, EE. Species-specific differences in translational regulation of dihydrofolate reduc-tase. Mol. Pharmacol 76:723-733; 2009.
10. Skacel, N; Menon, LG; Mishra, PJ; Peters, R; Banerjee, D; Bertino, JR; Abali, EE. Identification of amino acids required for the functional up-regulation of human dihydrofolate reductase protein in response to antifolate treatment. J. Biol. Chem 280:22721-22731; 2005. (Pubitemid 40853177)
11. Chalupsky, K; Cai, H. Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 102:9056-9061; 2005. (Pubitemid 40881077)
12. Sugiyama, T; Levy, BD; Michel, T. Tetrahydrobiopterin recycling, a key determinant of endothelial nitric-oxide synthase-dependent signaling pathways in cultured vascular endothelial cells. J. Biol. Chem 284:12691-12700; 2009.
13. Moens, AL; Ketner, EA; Takimoto, E; Schmidt, TS; O'Neill, CA; Wolin, MS; Alp, NJ; Channon, KM; Kass, DA. Bi-modal dose-dependent cardiac response to tetrahydrobiopterin in pressure-overload induced hypertrophy and heart failure. J. Mol. Cell. Cardiol 51:564-569; 2011.
14. Crabtree, MJ; Hale, AB; Channon, KM. Dihydrofolate reductase protects endothelial nitric oxide synthase from uncoupling in tetrahydrobiopterin deficiency. Free Radic. Biol. Med 50:1639-1646; 2011.
15. Mayahi, L; Heales, S; Owen, D; Casas, JP; Harris, J; MacAllister, RJ; Hingorani, AD. (6R)-5,6,7,8-Tetrahydro-l-biopterin and its stereoisomer prevent ischemia reperfusion injury in human forearm. Arterioscler. Thromb. Vasc. Biol 27:1334-1339; 2007. (Pubitemid 46809422)
16. Katusic, ZS. Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? Am. J. Physiol. Heart Circ. Physiol 281:H981-H986; 2001.
17. Worthley, MI; Kanani, RS; Sun, YH; Sun, Y; Goodhart, DM; Curtis, MJ; Anderson, TJ. Effects of tetrahydrobiopterin on coronary vascular reactivity in atherosclerotic human coronary arteries. Cardiovasc. Res 76:539-546; 2007. (Pubitemid 350007453)
18. Fukuda, Y; Teragawa, H; Matsuda, K; Yamagata, T; Matsuura, H; Chayama, K. Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia. Heart 87:264-269; 2002. (Pubitemid 34177685)
19. Cosentino, F; Hürlimann, D; Delli Gatti, C; Chenevard, R; Blau, N; Alp, NJ; Channon, KM; Eto, M; Lerch, P; Enseleit, F; Ruschitzka, F; Volpe, M; Lüscher, TF; Noll, G. Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia. Heart 94:487-492; 2008. (Pubitemid 351441407)
20. Moffat, J; Grueneberg, DA; Yang, X; Kim, SY; Kloepfer, AM; Hinkle, G; Piqani, B; Eisenhaure, TM; Luo, B; Grenier, JK; Carpenter, AE; Foo, SY; Stewart, SA; Stockwell, BR; Hacohen, N; Hahn, WC; Lander, ES; Sabatini, DM; Root, DE. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124:1283-1298; 2006.
21. Whitsett, J; Picklo Sr MJ; Vasquez-Vivar, J. 4-Hydroxy-2-nonenal increases superoxide anion radical in endothelial cells via stimulated GTP cyclohydro-lase proteasomal degradation. Arterioscler. Thromb. Vasc. Biol 27:2340-2347; 2007. (Pubitemid 350203948)
22. Kalivendi, S; Hatakeyama, K; Whitsett, J; Konorev, E; Kalyanaraman, B; Vásquez-Vivar, J. Changes in tetrahydrobiopterin levels in endothelial cells and adult cardiomyocytes induced by LPS and hydrogen peroxide-a role for GFRP? Free Radic Biol. Med 38:481-491; 2005. (Pubitemid 40247438)
23. Antikainen, NM; Smiley, RD; Benkovic, SJ; Hammes, GG. Conformation coupled enzyme catalysis: single-molecule and transient kinetics investigation of dihydrofolate reductase. Biochemistry 44:16835-16843; 2005. (Pubitemid 43007212)
24. Widder, JD; Chen, W; Li, L; Dikalov, S; Thöny, B; Hatakeyama, K; Harrison, DG. Regulation of tetrahydrobiopterin biosynthesis by shear stress. Circ. Res. 101:830-838; 2007. (Pubitemid 350287198)
25. Cai, S; Alp, NJ; McDonald, D; Smith, I; Kay, J; Canevari, L; Heales, S; Channon, KM. GTP cyclohydrolase I gene transfer augments intracellular tetrahydro-biopterin in human endothelial cells: effects on nitric oxide synthase activity, protein levels and dimerisation. Cardiovasc. Res 55:838-849; 2002.
26. Crabtree, MJ; Smith, CL; Lam, G; Goligorsky, MS; Gross, SS. Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS. Am. J. Physiol. Heart Circ. Physiol 294:H1530-H1540; 2008. (Pubitemid 351492501)
27. Rosenkranz-Weiss, P; Sessa, WC; Milstien, S; Kaufman, S; Watson, CA; Pober, JS. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells: elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J. Clin. Invest 93:2236-2243; 1994.
28. Biondi, R; Ambrosio, G; De Pascali, F; Tritto, I; Capodicasa, E; Druhan, LJ; Hemann, C; Zweier, JL. HPLC analysis of tetrahydrobiopterin and its pteridine derivatives using sequential electrochemical and fluorimetric detection: application to tetrahydrobiopterin autoxidation and chemical oxidation. Arch. Biochem. Biophys 520:7-16; 2012.
29. Bailey, SW; Ayling, JE. Separation and properties of the 6-diastereoisomers of l-erythro-tetrahydrobiopterin and their reactivities with phenylalanine hydro-xylase. J. Biol. Chem 253:1598-1605; 1978. (Pubitemid 8303465)
30. Goldman, ID; Matherly, LH. Biochemical factors in the selectivity of leucovorin rescue: selective inhibition of leucovorin reactivation of dihydrofolate reduc-tase and leucovorin utilization in purine and pyrimidine biosynthesis by methotrexate and dihydrofolate polyglutamates. Natl. Cancer Inst. Monogr 5:17-26; 1987. (Pubitemid 18000391)
31. Tsay, JT; Appleman, JR; Beard, WA; Prendergast, NJ; Delcamp, TJ; Freisheim, JH; Blakley, RL. Kinetic investigation of the functional role of phenylalanine-31 of recombinant human dihydrofolate reductase. Biochemistry 29:6428-6436; 1999.
32. Williams, EA; Morrison, JF. Human dihydrofolate reductase: reduction of alternative substrates, pH effects and inhibition by deazafolates. Biochemistry 31:6801-6811; 1992.
33. Appleman, JR; Beard, WA; Delcamp, TJ; Prendergast, NJ; Freisheim, JH; Blakley, RL. Unusual transient- and steady-state kinetic behavior is predicted by the kinetic scheme operational for recombinant human dihydrofolate reductase. J. Biol. Chem 265:2740-2748; 1990.
34. Webber, S; Whiteley, JM. Comparative activity of rat liver dihydrofolate reductase with 7,8-dihydrofolate and other 7,8-dihydropteridines. Arch. Biochem. Biophys 236:681-690; 1985. (Pubitemid 15137875)
35. Kinoshita, H; Milstien, S; Wambi, C; Katusic, ZS. Inhibition of tetrahydrobiop-terin biosynthesis impairs endothelium-dependent relaxations in canine basilar artery. Am. J. Physiol 273:H718-H724; 1997.
36. Davis, MD; Kaufman, S; Milstien, S. The auto-oxidation of tetrahydrobiopterin. Eur. J. Biochem. 173: 345-351; 1998.
37. Wei, CC; Crane, BR; Stuehr, DJ. Tetrahydrobiopterin radical enzymology. Chem. Rev. 103:2365-2383; 2003.
38. Capeillere-Blandin, C; Mathieu, D; Mansuy, D. Reduction of ferric haemopro-teins by tetrahydropterins: a kinetic study. Biochem. J. 392:583-587; 2005. (Pubitemid 43022738)
39. Fiege, B; Ballhausen, D; Kierat, L; Leimbacher, W; Goriounov, D; Schircks, B; Thöny, B; Blau, N. Plasma tetrahydrobiopterin and its pharmacokinetic following oral administration. Mol. Genet. Metab. 81:45-51; 2004. (Pubitemid 38064431)
40. Cunnington, C; Van Assche, T; Shirodaria, C; Kylintireas, I; Lindsay, AC; Lee, JM; Antoniades, C; Margaritis, M; Lee, R; Cerrato, R; Crabtree, MJ; Francis, JM; Sayeed, R; Ratnatunga, C; Pillai, R; Choudhury, RP; Neubauer, S; Channon, KM. Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease. Circulation 125:1356-1366; 2012.
41. Gao, L; Chalupsky, K; Stefani, E; Cai, H. Mechanistic insights into folic acid-dependent vascular protection. Dihydrofolate reductase (DHFR)-mediated reduction in oxidant stress in endothelial cells and angiotensin II-infused mice: a novel HPLC-based fluorescent assay for DHFR activity. J. Mol. Cell. Cardiol 47:752-760; 2009.